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ABSTRACT
CRISPR (clustered regularly interspaced short palin-
dromic repeat) endonucleases are at the forefront of
biotechnology, synthetic biology and gene editing.
Methods for controlling enzyme properties promise
to improve existing applications and enable new
technologies. CRISPR enzymes rely on RNA cofac-
tors to guide catalysis. Therefore, chemical modifi-
cation of the guide RNA can be used to character-
ize structure-activity relationships within CRISPR ri-
bonucleoprotein (RNP) enzymes and identify com-
patible chemistries for controlling activity. Here,
we introduce chemical modifications to the sugar–
phosphate backbone of Streptococcus pyogenes
Cas9 CRISPR RNA (crRNA) to probe chemical and
structural requirements. Ribose sugars that pro-
moted or accommodated A-form helical architecture
in and around the crRNA ‘seed’ region were tol-
erated best. A wider range of modifications were
acceptable outside of the seed, especially D-2′-
deoxyribose, and we exploited this property to facil-
itate exploration of greater chemical diversity within
the seed. 2′-fluoro was the most compatible mod-
ification whereas bulkier O-methyl sugar modifica-
tions were less tolerated. Activity trends could be
rationalized for selected crRNAs using RNP stability
and DNA target binding experiments. Cas9 activity
in vitro tolerated most chemical modifications at pre-
dicted 2′-hydroxyl contact positions, whereas edit-
ing activity in cells was much less tolerant. The bio-
chemical principles of chemical modification identi-
fied here will guide CRISPR-Cas9 engineering and
enable new or improved applications.
INTRODUCTION
CRISPR (Clustered Regularly Interspaced Short Palin-
dromic Repeats) is an adaptive immune defence system
that evolved to combat foreign invading nucleic acids in
bacteria and archaea (1–6). Their core enzymatic compo-
nent typically comprises a CRISPR-associated (Cas) en-
donuclease bound to CRISPR RNA (crRNA) cofactors
that guide sequence-specific binding and subsequent phos-
phodiester bond cleavage of double-stranded DNA (7,8).
A well-characterized and prototypical system is CRISPR-
Cas9 from Streptococcus pyogenes (8,9). The S. pyogenes cr-
RNA is complementary to target DNA at its 5′ guide and
base-pairs with a trans-activating crRNA (tracrRNA) via
its 3′ repeat sequence. The tracrRNA uses 3′ stem-loops to
bind Cas9 while the crRNA makes several direct Cas9 con-
tacts, including six predicted 2′-hydroxyl contacts (Figure
1A) (7,10,11). TheS. pyogenesCas9 can also use an artificial
single-guide RNA (sgRNA) where the crRNA and tracr-
RNA are artificially fused together (8,12,13).
CRISPR systems are being actively co-opted for biotech-
nology, therapeutics and synthetic biology (14,15) and fur-
ther development will depend on a more detailed under-
standing of mechanistic principles (7,16). Chemical mod-
ification of RNA is an effective method to probe mecha-
nism andRNA–protein relationshipswithin ribonucleopro-
tein (RNP) enzymes (17). Ribose modifications can charac-
terize the contributions of RNA to helical structure, ster-
ics, flexibility, sugar pucker and 2′-hydroxyl requirements
(18). In addition, chemical modifications can impart nucle-
ase resistance, improved bioavailability and increased target
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Figure 1. Dual RNA-guided Cas9 and sugar–phosphate chemical modifications. (A) Sequence and secondary structure of a dual RNA guide for Strep-
tococcus pyogenes Cas9. Asterisks indicate structure-predicted 2′-OH contacts with Cas9. (B) Chemically modified nucleotides and linkers used in this
study.
affinity (19,20). Ribose modification has been the subject of
efforts to enhance the binding, stability and function of nu-
cleic acids in antisense oligonucleotide (AON), RNA inter-
ference (RNAi) and aptamer technologies. Chemical modi-
fications at the 2′-position of the sugar ring have been indis-
pensable for transitioning nucleic acids into FDA-approved
drugs (21,22). It is likely that CRISPR-based technolo-
gies will also benefit from chemical modification of RNA
(14,23–25).
Several studies have focused on chemical modification
of crRNA, tracrRNA and sgRNA for their compatibil-
ity with gene editing applications (25–30). However, these
studies primarily relied on a limited set of commercially
available modifications to maintain gene editing, which in-
volves multiple steps and poorly understood mechanisms
inside of cells. The application-driven nature of these studies
has made it difficult to extract guidelines based on enzyme
structure or intrinsic biochemical mechanisms. For exam-
ple, it has been concluded by several studies that RNA can-
not be removed at certain positions, particularly the ‘seed’
region or those that make 2′-hydroxyl contacts with Cas9
(27–29,31). However, we previously found that Cas9 bio-
chemical cleavage activity was unaffected when all of the
RNA residues at these critical positions were simultane-
ously substituted with DNA (32). To better understand the
underlying rules governing crRNA modification, we incor-
porated a broader andmore diverse set of 2′-modifiedDNA
and RNA analogues in crRNA and characterized their im-
pact on Cas9’s cleavage activity. We sought to specifically
address the biochemical requirement of RNA by investigat-
ing the role of A-form structure, conformational flexibility
and steric constraints.
Here, we identify guidelines for modification of crRNA
that are compatible with Cas9 biochemical activity. We
propose that the seed region of crRNA guides prefer an
A-form-like architecture whereas the tracrRNA-pairing
(tracr-pairing) repeat region is compatible with a broader
array of modifications, includingDNA, 2′F-ANA and 2′,5′-
RNA. Despite strong A-form conformational preference,
relatively bulky modifications such as C2′- or C4′-OMe
groups were only tolerated in the seed when minimal re-
placements were made. The RNA analogue 2′F-RNA was
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the most compatible modification in most positions. The
high compatibility of DNA nucleotides outside of the seed
region suggests that flexibility may be an important fac-
tor in conformational transitions of Cas9 (7,33,34). Chemi-
cal modification at positions of predicted Cas9–2′-hydroxyl
contacts reduced efficient gene editing in cells despite ef-
ficient cleavage activity in vitro. These results help eluci-
date the functional role of RNA and provide more ratio-
nal guidelines for chemical modification of CRISPR-Cas9
for synthetic biology, biotechnology and future therapeutic
applications.
MATERIALS AND METHODS
Chemically modified oligonucleotide synthesis
Standard phosphoramidite solid-phase synthesis condi-
tions were used for the synthesis of all modified and un-
modified oligonucleotides. Syntheses were performed on
an Applied Biosystems 3400 or Expedite DNA Synthe-
sizer at a 1 micromole scale using Unylink CPG sup-
port (ChemGenes). All phosphoramidites were prepared
as 0.15 M solutions in acetonitrile (ACN), except DNA,
whichwas prepared as 0.1M solutions. 5-Ethylthiotetrazole
(0.25 M in ACN) was used to activate phosphoramidites
for coupling. Detritylations were accomplished with 3%
trichloroacetic acid in CH2Cl2 for 110 s. Capping of
failure sequences was achieved with acetic anhydride in
tetrahydrofuran (THF) and 16% N-methylimidazole in
THF. Oxidation was done using 0.1M I2 in 1:2:10 pyri-
dine:water:THF. Coupling times were 10–15 min for RNA,
2′F-ANA, 2′F-RNA, 2′F,4′OMe-RNA, 2′,4′-diOMe-RNA
and LNA phosphoramidites. Mixed sugar modifications
were prepared using premixed 1:1 equivalents of RNA 2′-
amidite with RNA 3′-amidite, or 1:1 equivalents of RNA
2′-amidite or DNA 3′-amidite, or 1:1 equivalents of RNA
2′-amidite with 2′F-RNA 3′-amidite. This 1:1 ratio results
in ∼0.77:1 incorporation of 2′-amidite to 3′-amidite. De-
protection and cleavage from the solid support was ac-
complished with either 3:1 NH4OH:EtOH for 48 h at
room temperature (RT), or at 55◦C for 16 h. Oligonu-
cleotides containing RNA were synthesized with stan-
dard 2′-TBDMS phosphoramidites, and desilylation was
achieved with either neat triethylamine trihydrofluoride for
48 h at RT, or with triethylamine trihydrofluoride/N-methyl
pyrrolidone/triethylamine (1.5:0.75:1 by volume) for 2.5 h
at 65◦C. Crude oligonucleotides were purified by anion ex-
change HPLC on an Agilent 1200 Series Instrument using
a Protein-Pak DEAE 5PW column (7.5 × 75 mm) at a flow
rate of 1 ml/min. The gradient was 0–24% of 1 M LiClO4
over 30 min at 60◦C. Samples were desalted on NAP-25 de-
salting columns according to manufacturer protocol. Mod-
ified crRNAs were prepared for RNP assembly by heating
to 95◦C then placing on ice to prevent formation of stable
secondary structures.
RNA and RNA–DNA oligonucleotide synthesis
DNA oligonucleotides and DNA–RNA chimeric oligonu-
cleotides were synthesized by Integrated DNA Technolo-
gies (IDT). Chimeric crRNAs were prepared for RNP as-
sembly by heating to 95◦C then placing on ice to prevent
formation of stable secondary structures. Cas9 tracrRNAs
were prepared by T7RNApolymerase in vitro transcription
with DNA templates synthesized by IDT. Single-stranded
DNA templates were annealed to T7 promoter oligo to gen-
erate double-stranded promoter regions, which support in
vitro transcription by T7 RNA polymerase. In vitro tran-
scriptions were performed by standard protocols for 2 h.
Briefly, reactions contained purified T7 RNA polymerase
(4 M), 30 mM Tris (at pH 7.9), 12.5 mM NaCl, 40 mM
MgCl2, 2% PEG 8000, 0.05% Triton X-100, 2 mM spermi-
dine and 2.5 M T7-DNA template. Afterward, the DNA
template was degraded by DNase I treatment. Reactions
were phenol–chloroform extracted and gel-purified from
denaturing polyacrylamide gels. PurifiedRNAwas refolded
by heating to 95◦C for 5 min in a heating block followed by
slow cooling the block to RT (∼40 min). RNA was quanti-
fied by measuring absorbance at 260 nm and calculated ex-
tinction coefficients using nearest neighbor approximations
and Beer’s Law.
Preparation of Cas9 enzymes
Plasmid encoding an SpCas9 (simply referred to as Cas9)
with a C-terminal fusion of a nuclear localization signal
(NLS) and a 6x-Histidine tag (pET-Cas9-NLS-6xHis) was
obtained from Addgene (62933). A dead Cas9 (dCas9) ver-
sion was prepared by performing site-directed mutagen-
esis on this plasmid to generate H840A and D10A mu-
tations (pET-dCas9-NLS-6xHis). Cas9 proteins were pre-
pared similar to that previously described (35). Briefly, pro-
tein expression was induced in Rosetta (DE3) cells with
0.4 mM isopropyl -D-1-thiogalactopyranoside (IPTG) at
18◦C for 16 h. Cell pellets were resuspended in 12 ml of
chilled binding buffer (20 mM Tris–HCl, pH 8.0, 250 mM
NaCl, 1 mM PMSF, 5 mM imidazole) per 0.5 l of cul-
ture pellet. Resuspended cells were sonicated and clari-
fied by centrifugation. Supernatant was purified by His-
Pur Cobalt-CMA resin (Thermo Scientific) by sequentially
increasing concentrations of NaCl wash buffer (Tris–HCl,
pH 8, 0.25/0.5/0.75/1.0 M NaCl, 10 mM imidazole). Pro-
tein was eluted with 130 mM imidazole wash buffer. The
eluent was concentrated and exchanged into 2x Cas9 stor-
age buffer (40 mM HEPES-KOH, pH 7.5, 300 mM KCl, 2
mM ethylenediaminetetraacetic acid (EDTA), 2 mMDTT)
then one volume of glycerol added. Concentration was de-
termined by UV absorbance at 280 nm using a calculated
extinction coefficient (120 450 M−1 cm−1) and Beer’s law.
In vitro Cas9 cleavage activity assays
In vitro cleavage assays were performed as previously de-
scribed (32). Linearized plasmid target DNA (100 ng) har-
boring the tetracycline receptor (TR) gene or EGFP (EG)
were combined with the Cas9 RNP complex (0.75 M
Cas9, 0.25 M tracrRNA, 0.3 M crRNA final concen-
tration) in a 1× cleavage buffer (20 mM Tris–HCl, pH 7.5,
100 mM KCl, 5% glycerol, 1 mM DTT, 0.5 mM EDTA, 2
mMMgCl2) supplemented with 0.1 mg/ml of purified yeast
tRNA. The concentration of tracrRNA was purposely set
as the limiting component of the RNP complex and used to
predict final RNP concentration. Molar excess of Cas9 and
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crRNA will ensure complete assembly of tracrRNA into
RNP complexes and does not result in aggregation at con-
centrations used in our assays (32). Standard reaction con-
ditions were 37◦C for 2 h in a final reaction volume of 40 l.
The mixture was treated with 10 g of RNase A (Thermo
Scientific) for 15 min followed by 20 g of Proteinase K
(Thermo Scientific) for 15 min at room temperature. The
DNA products were precipitated in 10 volumes of acetone
with 2% LiClO4 at −20◦C for >1 h. DNA cleavage prod-
ucts were resolved by agarose electrophoresis and visual-
ized using ethidium bromide staining. The fraction of target
plasmid cleaved was quantified using ImageJ software. The
band intensity for the cleavage product band was divided
by the combined intensity of the largest cleavage product
and uncut substrate plasmid bands and reported as fraction
cleaved (i.e. ‘cut’/‘cut + uncut’). Error bars for all quan-
tified data represent experimental replicates, not technical
replicates. Sample size was selected based on the expecta-
tion that three or more replicates will be representative of
typical in vitro assay conditions.
Radiolabeling of DNA target
A total of 100 pmols of antisense DNA target strand
was radiolabeled with [ - 32P]-ATP using T4 polynu-
cleotide kinase following the manufacturer’s recommended
enzyme protocol (Thermo Fisher). Reactions were phenol-
chloroform extracted and radiolabeled DNA was gel-
purified on 15% denaturing polyacrylamide gels by the
crush-and-soak method. Gel-purified radiolabeled RNA
and DNA was quantified by scintillation counting.
Dot-blot filter binding assays for duplex target binding
For target binding by Cas9 RNP complexes, radiolabeled
duplex target DNA (1000 cpm/reaction) was combined
with increasing concentrations of a pre-assembled dCas9–
tracrRNA–crRNA complex in a final reaction of 20 l 1×
cleavage buffer and 0.1 mg/ml tRNA. After incubation at
37◦C for 15 min, reactions were vacuum filtered over nitro-
cellulose membrane (Protran PremiumNC,Amersham) us-
ing a 96-well dot blot apparatus. Wells were washed twice
with 200 l of 1× cleavage buffer. Membrane was then re-
moved and washed with 1× PBS solution three times and
air dried atRT. Binding of radiolabeledDNAwas then visu-
alized by GE Typhoon phosphorimager. Spots were quan-
tified with ImageQuant software, values plotted in Prism
(GraphPad) and data fit to a one-site binding hyperbola
equation.
Thermal denaturation monitored by UV absorbance
Thermal denaturation was as previously described (32).
Cas9 alone or complexed to tracrRNA and crRNA at 1M
final concentration (equimolar concentrations of all com-
ponents) was incubated at room temperature for 10 min in
degassed 1× UV melt buffer (20 mM Cacodylate, pH 7.5,
150mMKCl, 1mMMgCl2). Samples weremelted in aCary
400 UV/Vis spectrophotometer at a ramp rate of 1◦C/min
while UV absorbance at 280 nm was collected every 1 min.
Experiments were repeated in duplicate. Melting tempera-
tures were determined using Van’t Hoff calculations and er-
ror determined by standard error of the mean using two ex-
perimental replicates for each sample.Melt data was plotted
using Prism (GraphPad) software.
Cell-based editing measured by flow cytometry
HEK 293T cells expressing EGFP and SpCas9 were a kind
gift fromWenXue (UMassMedical Center) (29). Cells were
grown in Dulbecco’s modified eagle’s medium (DMEM)
with 1× non-essential amino acids (NEAA), 5% Cosmic
calf serum (CCS) and 2.5% fetal bovine serum (FBS) with-
out antibiotics. Cells were reverse transfected (40–50 000
cells) in four experimental replicates in 96-well plates with
20 pmols of crRNA:tracrRNA complex in a final of 200
l using RNAiMAX (Invitrogen) following the manufac-
turer’s recommended protocol. After 12 h, one volume of
media containing 15%FBS and 1× Penicillin-Streptomycin
solution was added to the Opti-MEM and cells incubated
for an additional 12 h. Media was then replaced with full
media and cells grown for an additional 4 days.
For flow cytometry, cells were washed with PBS,
trypsinized, washed again and then fixed with 1%
paraformaldehyde in PBS for 8 min. Cells were washed
again and counted in an Accuri C6 Flow Cytometer.
EGFP was detected using the blue laser at excitation 488
nm; emission detection 530 ± 15 nm (FL1 channel). At
least 20 000 events were collected and analyzed by Accuri
CFlow Plus software. The cells were first gated based on
forward and side scattering (FSC-A/SSC-A) to remove cell
debris, then gated to select single cells (FSC-H/FSC-A).
At last, cells were gated to select EGFP positive cells.
The quadrant gate was established using the signal from
non-EGFP expressing control cells. Untreated HEK
293T cells expressing EGFP and Cas9 contained ∼6%
non-fluorescent cells. The average from four replicates was
used for background subtraction to determine the extent
of cell-based editing after treatment.
RESULTS
We used a dual RNA-guided (separate crRNA and tracr-
RNA) S. pyogenes CRISPR-Cas9 to probe the role of
the guide RNA in enzyme activity (Figure 1A). As op-
posed to an artificial single-guide RNA (sgRNA) (8), dual
RNA-guided Cas9 reflects the naturally occurring enzyme
(36,37). Given their shorter length, dual guides are also
more amenable to chemical modification (28). To facilitate
more efficient crRNA chemical synthesis, we truncated a cr-
RNA by 2 nt at the 5′ end and 4 nt at the 3′ end to yield a 36
nt crRNA (28). For this study, we have selected several mod-
ified nucleotides with properties that mimic or antagonize
the properties of RNA (Figure 1B). To isolate and compare
the effects of these modifications, we initially used a guide
sequence targeting the tetracycline receptor (TR) gene and
quantified site-specific in vitro cleavage of a linearized plas-
mid (Supplementary Figure S1) (32).
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Complete crRNA modification can support target DNA
cleavage activity
To establish a baseline for modification effects, we com-
pletely modified a native crRNA (crTR1) to 2′F-RNA
(crTR2), a modification that strongly mimics RNA sugar
pucker but cannot donate hydrogen bonds (38) (Figure 2).
Enzyme activity was very high, comparable to crTR1, sug-
gesting that strong A-form conformation and small chemi-
cal changes are preferred whereas hydrogen bonding may
be less important. We also synthesized a control crRNA
composed entirely of DNA (crTR3). Consistent with our
earlier report, crTR3 did not support target DNA cleavage
(32). A DNA–DNA hybrid with the target would adopt a
B-form helical structure (39) not easily accommodated by
Cas9 (10,11).
2′,5′-RNA is an RNA mimic where 3′,5′-phosphodiester
linkages are replaced by the regioisomeric 2′,5′ linkage; it
binds to complementary native RNA with good affinity,
and incorporation of a few 2′,5′ linkages into an otherwise
unmodified RNA strand has a minor impact on duplex sta-
bility (40). The 2′,5′-RNA modification is known to induce
‘A-like’ structure on oligonucleotides and sequences con-
taining this modification prefer to hybridize to RNA over
single-stranded DNA (ssDNA) (41,42). Thus, 2′,5′ linkages
should serve as an alternativeA-form structure probe. Com-
plete conversion of a crRNA to 2′,5′-RNA abrogated en-
zyme activity (crTR4), possibly reflecting its poor affinity
towards single-stranded DNA. To mitigate overpowering
effects of 2′,5′ modifications at individual positions and gen-
erate a more moderate probe, we incorporated a mixture
of 2′,5′ and 3′,5′ linkages at each position. Recent high-
resolution crystallographic data on mixed-backbone RNA
duplexes show that RNA duplexes containing a few 2′,5′
linkages share the same global A-like structure as the na-
tive duplex (41,43). Remarkably, RNAhelical structures are
well retainedwith 40%backbone heterogeneity (43). The re-
sult is a mixed population of crRNA regioisomers with the
same base sequence. The resulting crRNA crTR5 consisted
of a statistical mixture of 235 (or 3.44 × 1010) isomers. A
similar isomeric effect is observed with phosphorothioate
linkages, which has not been a major hurdle for their use in
development of FDA-approved drugs like Nusinersen (44).
Incorporating 3′,5′ linkages into the inactive 2′,5′-crRNA
strand significantly restored activity (crTR4 versus crTR5),
albeit not to the level of a native 3′,5′ crRNA (crTR1). Com-
bining 2′,5′-RNA with 2′F-RNA in a mixed configuration
(crTR6) also provided substantial activity, also supporting
the A-form-like structural accommodation of 2′,5′ linkages.
We and others have previously found that Cas9 en-
zymes can accept partial RNA–DNA chimeric crRNAs
(29,31,32). In particular, converting the entire tracr-pairing
region to DNA significantly enhanced cleavage activity and
maintained or enhanced specificity (32). Thus, we rational-
ized that synergy might be achieved by taking into con-
sideration the modular nature of the crRNA. We modi-
fied the guide and tracr-pairing regions independently and
confirmed that DNA in the tracr-pairing region was highly
compatible with our target sequence (crTR7) (32). DNA in
this region will pair with RNA in the tracrRNA and likely
maintain an A-form architecture while increasing confor-
mational freedom (32). While keeping DNA in the tracr-
pairing region, we then substituted 2′F-RNA (crTR8), 2′,5′-
RNA (crTR9), RNA/2′,5′-RNA mixed nucleotide modi-
fication (crTR10) and 2′F-ANA (crTR11) into the guide
region. The 2′F-RNA configuration was very compatible,
supporting high activity. The 2′,5′-RNA and RNA/2′,5′-
RNA mixed nucleotides exhibited little or no activity.
The guide/seed region strongly prefers A-form helical struc-
ture
2′F-ANA (2′-deoxy-2′-fluoro-arabinonucleic acid), the 2′
epimer of 2′F-RNA, is known to acquire a C2′/O4′-endo
sugar pucker and prefer a B-form helix (45,46), which re-
sults in more DNA-like properties but with less flexibility.
The 2′F-ANA configuration (crTR11) was inactive. These
results suggested that the guide region is more reliant on
A-form helical structure than the tracr-pairing region. This
is not unexpected since it will pair with a DNA target
and must assume an A-form-like conformation for effi-
cient catalysis (10,11). We therefore tested B-form confor-
mational preference in the tracr-pairing region by substi-
tuting in 2′F-ANA (crTR12). This modification configu-
ration was also completely inactive. Since 2′F-ANA lacks
the conformational flexibility of DNA (45), it is likely that
2′F-ANA in certain tracr-pairing positions is incompatible
due to inflexibility. In support of this possibility, we found
that a crRNAwith a 2′F-RNA guide and a 2′F-ANA tracr-
pairing region could support high cleavage activity when
the first 4 nt of the tracr-pairing region were DNA residues
(crTR13).
Within the crRNAguide region is a ‘seed’ sequencewhere
crRNA pairing to a target DNA is nucleated (7). Pre-
vious investigations reported that seed sequence residues
cannot be fully modified and specific positions require
RNA (27–29,31). Likewise, crystal structures have predicted
crRNA 2′-hydroxyl contacts with Cas9 (10,11). Arguing
against a strict requirement for 2′-hydroxyl contacts, we
previously showed that all predicted contacts could be si-
multaneously converted to DNA in an otherwise native
crRNA with no effect on biochemical activity (32). To
probe the seed sequence, we substituted eight contiguous
seed residues while maintaining RNA in the rest of the
crRNA. DNA (crTR14), as well as a mixed RNA/2′,5′-
RNA strand (crTR15), provided high activity, indicating
that predicted 2′ polar contacts are of limited importance.
However, complete conversion of the seed to 2′,5′-RNA
(crTR16) or 2′F-ANA (crTR17) resulted in little or no ac-
tivity. To determine the importance of flanking nucleotide
conformation on the seed region, we started with 2′,5′-RNA
or 2′F-ANA in the seed and then substituted flanking re-
gions with various modifications (crTR18-crTR24). None
of these combinations supported activity, suggesting an in-
ability to strongly influence seed structure. Therefore, the
seed region appears to strongly prefer A-form helical struc-
ture and is not significantly impacted by flanking modifica-
tions. An exception may be observed for conformationally
flexible nucleotides like DNA (crTR14).
Based on the above results, we tested a variety of ‘al-
timers’ where two or more modifications are alternated in a
pattern (47). Altimers can exploit unique synergy between
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crTR12 5’ 3’
crTR11 5’ 3’
0.5 1.00
Fraction cleaved
RNA/2’,5’-RNA
crTR5 5’ 3’
crTR10 5’ 3’
RNA DNA
* * * * * *
crTR15
crTR14 5’ 3’
crTR16
crTR17 5’ 3’
5’ 3’crTR23
crTR24 5’ 3’
crTR25 5’ 3’
crTR26 5’ 3’
crTR27 5’ 3’
crTR28 5’ 3’
crTR29 5’ 3’
5’ 3’crTR30
crTR31 5’ 3’
crTR32 5’ 3’
crTR33 5’ 3’
crTR34 5’ 3’
5’ 3’
crTR22 5’ 3’
crTR21 5’ 3’
crTR20 5’ 3’
crTR19 5’ 3’
crTR18 5 3’
5’ 3’
crTR9 3’5’
crTR4 5’ 3’
2’,5’-RNA
2’F-RNA/2’,5’-RNA
crTR6 5’ 3’
crTR13 5’ 3’
Figure 2. Modification schemes and the corresponding Cas9 enzyme activity for chemically modified crRNAs. Entire crRNAs or large sequence tracts in
the guide, seed or tracrRNA-pairing region are modified. crRNA sequence is shown above and structure-predicted 2′-OH contacts with Cas9 are indicated
with asterisks below. Enzyme activity is reported to the right. Error is reported as standard error of the mean (s.e.m.) for three or more replicates.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gky1214/5229206 by Southern Illinois U
niversity C
arbondale,  ktgagnon@
siu.edu on 04 D
ecem
ber 2018
Nucleic Acids Research, 2018 7
adjacent modifications and modulate effects. Indeed, al-
timers of DNA and 2′F-ANA in the tracr-pairing region
supported high activity when coupled with RNA (crTR25)
or 2′F-RNA (crTR28) in the guide region. The seed re-
gion was not compatible with altimer configurations us-
ing 2′F-ANA (crTR29-crTR31). However, altimers of 2′F-
RNA and DNA across the seed region were generally toler-
ated (crTR32-crTR34), further supporting a predominant
role for A-form conformational effects and the benefit of
conformational flexibility (32).
Our previous study characterizing RNA–DNA chimeric
crRNAs found that RNA residues in the seed region alone,
with DNA in all other positions, was sufficient to sup-
port robust in vitro enzyme activity by Cas9 (32). We con-
firmed this effect (crTR35) and used the high compatibil-
ity of DNA outside of the seed region to further probe the
structural and conformational requirements of the seed re-
gion (Figure 3). In this configuration, there is a lack of
strong interference from flanking sequence because of the
relative conformational neutrality of DNA. Once again,
we found that 2′F-RNA was a suitable replacement for
RNA (crTR36). As well, 2′,5′-RNA (crTR38) or 2′-FANA
(crTR39) in the seed region showed little activity. Mixed
linkages (2′,5′/3′,5′-RNA) in the seed were more efficient
(crTR37) than 2′,5′-RNA, reinforcing our earlier observa-
tion that RNA can help mitigate the structural effects of
2′,5′-linkages.
We wanted to explore more diverse modifications, some
of which are only available as uridines. Therefore, we mod-
ified the six uridines in the 8-nt seed region while keeping
all other positions DNA. With only six uridine nucleotides
to modify, we explored replacement of RNA (crTR40)
with 2′F-RNA (crTR41), 2′,5′-RNA (crTR42), 2′F-ANA
(crTR43), DNA (crTR44) (to distinguish thymine versus
uracil effects), 2′,4′-di-C-OMe RNA (crTR45) and 2′F-
4′-C-OMe RNA (crTR46) (48–51). Other than 2′F-RNA,
and to a small degree 2′,5′-RNA, none of these modifi-
cations supported activity. This was surprising given the
RNA-like (C3′-endo) sugar pucker previously reported for
2′,4′-di-C-OMe and 2′F-4′-C-OMe (48,50,51). Multiple
4′-O-methyl groups may introduce unfavorable steric con-
straints due to their bulkiness relative to a hydrogen atom.
Nearest neighbor effects can also modulate the confor-
mation or properties of adjacent nucleotides. For example,
DNA is easily induced into A-form-like conformation by
neighboring RNA nucleotides (52,53). Likewise, juxtapos-
ing 2′F-ANA and 2′F-RNAnext to each other can relax the
strong RNA-like properties of 2′F-RNA (54). To determine
whether nearest neighbor effects could make modifications
work synergistically, we combined RNA with 2′F-ANA in
the seed (crTR47 and crTR48). RNA was unable to im-
prove activity for 2′F-ANA in the seed. Combining RNA
with 2′,5′-RNA (crTR49), 2′,4′-di-C-OMe (crTR50), or
2′F-4′-C-OMe (crTR51) also resulted in no activity. Thus,
RNA was unable to offset the unfavorable effects of these
modifications. In contrast, combining RNA with 2′F-RNA
(crTR52 and crTR53) and LNA (crTR54), a 2′-4′ bridging
modification that locks C3′-endo sugar pucker (55), resulted
in robust enzyme activity. Combining 2′F-RNA (with and
without RNA) with 2′F-ANAwas unable to restore activity
(crTR55 and crTR56). Attempting to increase conforma-
tional freedom by placing a UNA nucleotide (56) (crTR57)
or butane linker (crTR58) at the very 3′ nucleotide of the
seed region did not restore activity.
2′F-ANA was well tolerated in the tracr-pairing region,
as long as a few of the first 5′ nucleotides were DNA
(crTR13 and crTR59). However, placement of 2′F-ANA at
the second position (along with the fifth and eleventh po-
sitions) in the tracr-pairing region (crTR60) abrogated ac-
tivity. Combined with the activity of 2′F-ANA-containing
crRNAs crTR12, crTR13, crTR25, crTR27 and crTR28,
this result suggests that one or more positions closest to the
seed must assume A-form structure, either through confor-
mational predisposition or flexibility. DNAmay temper the
formation of A/B junctions or rigid versus flexible A-form
transitions between the seed and tracr-pairing region. Place-
ment of 2′F-ANA outside of the seed but still in the guide
region (crTR61 and crTR62) was also detrimental to ac-
tivity. Conversely, placing 2′F-RNA in the same guide and
tracr-pairing positions resulted in robust activity (crTR63
and crTR64). These results reinforce a strong preference for
A-form helical structure in the guide region, especially the
seed sequence and a greater tolerance for modification in
most of the tracr-pairing region. This difference may derive
from hybridization of the crRNA 5′ guide region to a DNA
target versus pairing of the 3′ region to a tracrRNApartner.
To further probe the role of RNA in the seed re-
gion, we replaced two uridines that are predicted to
mediate 2′-hydroxyl contacts (10,11) while maintaining
RNA in all other positions (crTR65-crTR70). Replace-
ment with 2′F-RNA was the most compatible (crTR65),
while DNA (crTR66), 2′F-4′-C-OMe (crTR67), 2′,4′-di-
C-OMe (crTR68) and even 2′F-ANA (crTR69) were well-
tolerated. The incorporation of 2′-O-methyl, a knownRNA
conformational mimic (57), was only moderately effective,
reinforcing steric issues with bulky modifications at the 2′
position. We selected only uridines for replacement, so se-
quence or base composition may influence modification ef-
fects. However, these results show that judicious placement
in a few seed positions can make modifications tolerable,
even in sensitive 2′-hydroxyl contact positions.
RNP stability, target DNA engagement and a second guide
sequence support crRNA activity trends
To rationalize the effect of modifications, we assembled
Cas9 RNP complexes and determined their thermal sta-
bility (Figure 4A) and their binding to a double-stranded
DNA target (Supplementary Figure S2 and Figure 4B).
Thermal stability was measured by absorbance at 280 nm
as temperature was increased (32). Cas9 alone exhibited a
melting temperature (Tm) of 44◦C. Upon assembly with a
tracrRNA, theTm increased to 46.6◦C.Higher order assem-
bly with native crRNA (crTR1) resulted in an additional
increase in the Tm, up to 49.5◦C. We selected a handful of
representative crRNAs to determine their impact on RNP
stability. Two crRNAs that provided high enzyme activity,
crTR2 and crTR35, fell into a high Tm regime like native
crRNA. One exception was crTR3, composed entirely of
DNA. This modified oligonucleotide seems to assemble sta-
ble RNP complexes but does not support catalysis (32). cr-
RNAs that fell into an intermediate Tm regime generally
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gky1214/5229206 by Southern Illinois U
niversity C
arbondale,  ktgagnon@
siu.edu on 04 D
ecem
ber 2018
8 Nucleic Acids Research, 2018
guide region tracr-pairing region
seed sequence
 AGAGCCAGCCUUCUUAUUGUUUUAGAGCUAUGCUGU5’ 3’
RNA DNA 
2’F-ANA
2’F-RNA LNA
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Fraction cleaved
crTR35 5’ 3’
crTR36 5’ 3’
crTR37
crTR38
crTR39 5’ 3’
crTR40 5’ 3’
crTR41 3’5’
crTR42
crTR43 5’ 3’
crTR44
crTR45
crTR46
crTR54 5’ 3’
crTR53 5’ 3’
crTR52 5’ 3’
crTR47 5’ 3’
crTR48 5’ 3’
crTR49
crTR50
crTR51
crTR55 5’ 3’
crTR56 5’ 3’
crTR57 5’ 3’
crTR63 5’ 3’
crTR64 5’ 3’
crTR59 5’ 3’
crTR61 5’ 3’
crTR58
crTR62 5’ 3’
crTR60 5’ 3’
5’ 3’
RNA/2’,5’-RNA
2’-deoxyU
5’ 3’
5’ 3’
2’,5’-RNA
5’ 3’
3’5’
5’ 3’
2’F, 4’-OMe
5’ 3’
5’ 3’
2’,4’-diOMe
3’5’
3’5’
* * * * * *
crTR65 5’ 3’
crTR66 5’ 3’
crTR67 5’ 3’
crTR68 5’ 3’
crTR69 3’5’
crTR70 5’ 3’
UNA
Butane linker
2’-OMe
Figure 3. Modification schemes investigating effects on Cas9 enzyme activity primarily at the seed region. crRNA sequence is shown above and structure-
predicted 2′-OH contacts with Cas9 are indicated with asterisks below. Enzyme activity is reported to the right. Error is reported as s.e.m for three or more
replicates.
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D
Figure 4. Thermal denaturation, target binding and a second guide sequence help rationalize crRNA activity trends. (A) RNP thermal denaturation
monitored by UV absorbance at 280 nm. Error is reported as s.e.m. for two replicates. (B) Substrate engagement measured by dot-blot filter binding of
radiolabeled target DNA. Error is reported as s.e.m. for three or more replicates. (C) In vitro cleavage activity of Cas9 RNPs assembled with chemically
modified crRNAs targeting an EGFP gene. crRNA sequence is shown above and structure-predicted 2′-OH contacts with Cas9 are indicated with asterisks
below. Enzyme activity is reported to the right. Error is reported as s.e.m. for three or more replicates. (D) Cell-based editing activity of crRNAs co-
transfected with tracrRNA into HEK 293T cells stably expressing EGFP and Cas9. Gene editing efficiency was measured as loss of EGFP fluorescence
by flow cytometry 5 days post-transfection. Error is reported as s.e.m. for four replicate treatments.
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supported moderate activity (crTR5 and crTR6). However,
crTR39, with 2′F-ANA in the seed, also fell into the in-
termediate Tm range. This result and the Tm of crTR3 il-
lustrate the modular nature of crRNAs where tracrRNA-
pairing might support assembly, yet the guide cannot sup-
port catalysis. Only crTR4, composed entirely of 2′-5′ link-
ages, did not increase RNP Tm. This crRNAmay be unable
to efficiently assemble a stable RNP complex with Cas9-
tracrRNA, explaining its lack of activity.
The ability of these chemicallymodified crRNAs to stably
engage target DNA mirrored the observations from RNP
stability (Figure 4B and Supplementary Figure S2). Native
crRNA (crTR1) facilitated strong equilibrium binding of
Cas9 RNP to target double-stranded DNA. Two crRNAs
with high activity and stable RNP assembly, crTR2 and
crTR35, exhibited moderate but stable target binding. cr-
RNAs with reduced enzyme activity (crTR3 and crTR4)
had lower target binding and those that possessed no cleav-
age activity did not bind the target. The all-DNA crTR3,
while able to assemble a stable RNP complex, was unable
to engage target DNA, as previously reported (32). Thus,
the effects of chemical modification can be correlated with
RNP assembly and target substrate engagement.
To determine if some of the general principles we have
observed could be extended to another sequence, we se-
lected a fewmodification schemes and a new guide sequence
that targets an EGFP gene. We performed in vitro cleavage
assays as before but using a linearized plasmid harboring
the EGFP gene as substrate (Figure 4C). A native crRNA
targeting EGFP (crEG1) supported about 90% cleavage of
the target plasmid. Complete modification with 2′F-RNA
(crEG2) resulted in substantial, albeit reduced, cleavage
at about 55%. As expected, complete conversion to DNA
(crEG3) or 2′,5′-RNA (crEG4) resulted in loss of activity.
For the crTR guide we showed that DNA outside of the
seed region was compatible with cleavage activity if the seed
contained modified nucleotides with appropriate RNA-like
properties. This was confirmed by testing either 2′F-ANA
or 2′F-RNA in the seed. The 2′F-ANA seed did not support
enzyme activity (crEG5) whereas 2′F-RNA in only six po-
sitions in the seed region was well-tolerated (crEG6). These
results support the overall preference for A-form like struc-
ture, especially in the seed region and the compatibility of
DNA in other regions of the crRNA.
To extend some of these results to Cas9 activity inside
of cells, we co-transfected tracrRNA and crRNA modified
with 2′F-RNA (crEG2) or 2′F-RNA and DNA (crEG6)
into HEK 293T cells stably expressing EGFP and Cas9.
These modified guides target EGFP and should result in
loss of EGFP expression if gene editing was successful.
Editing was measured by flow cytometry five days after
transfection. Despite high activity in vitro and the presence
of the strong RNA mimic 2′F-RNA, these guides failed to
produce substantial editing activity (Figure 4D). A recent
report suggested that modification at certain predicted 2′-
hydroxyl contacts is a bottleneck for complete modification
of editing-active crRNAs (27).
To focus on guides that might reveal the impact of chem-
ical modifications at these positions, we generated a new
set of modified crRNAs (crEG7-crEG12) against the same
EGFP sequence. In this case, however, only two predicted
2′-hydroxyl contact positions were modified. These modi-
fied crRNAs are similar to a subset tested in vitro in Fig-
ure 3 (crTR65-crTR70), but the modifications were placed
at two different positions. The positions chosen contained
uridine nucleotides to allow testing of a more diverse va-
riety of chemical modifications. These two positions were
also shown to be sensitive to modification in a previous re-
port (27).
In vitro cleavage revealed that these crRNAs either sup-
ported high activity (crEG7, 9, 10 and 12), moderate activ-
ity (crEG8), or no activity (crEG11) (Figure 4C). All except
crEG11 were subsequently co-transfected with tracrRNA
and their ability to support editing was measured by flow
cytometry. These crRNAs showed editing efficiencies that
were lower than an unmodified crRNA, but quite similar to
the trends observed in vitro (Figure 4D). These results un-
derscore the importance of predicted 2′-hydroxyl contacts
with Cas9 for maintaining high editing efficiency in cells.
They also support our in vitro observations regarding the
general compatibility of chemical modifications that prefer
or can assume A-form helical structure and are not steri-
cally bulky.
DISCUSSION
The potential use of CRISPR-Cas9 for gene editing in
patients, and its possible other applications in pharma-
cotherapy, will likely face key hurdles not unlike other
oligonucleotide-based therapeutics (19–22). Very early
work with AONs and siRNAs was undertaken with un-
modified, natural molecules. However, it soon became clear
that native oligonucleotides were subject to relatively rapid
degradation and lacked sufficient drug-like properties, such
as biodistribution or cellular uptake (19,58). Although
CRISPR-Cas9 is a largeRNP enzyme that possesses unique
challenges for drug development (14,23,24), it is anticipated
that chemical modification of the guide RNA will signifi-
cantly benefit certain therapeutic applications (59). Previ-
ous investigations into CRISPR-Cas9 RNA chemical mod-
ification have generally focused on screens for guide RNAs
that are tolerated in gene editing applications with an em-
phasis on nuclease resistance or off-target effects. These
have included modification of sgRNA with 2′-O-methyl,
2′F-RNA, and phosphorothioate (PS) or thiophospho-
noacetate linkages at the termini (26) or internal residues
(30), partial substitution of crRNAs with DNA (29) or 2′F-
RNA, 2′-O-methyl, 2′-4′ bridged nucleic acid and PS link-
ages (28), or site-specific incorporation of 2′-O-methyl-3′-
phosphonoacetate (25) and 2′-4′ bridged nucleic acids (60).
A recent study explored extensive structure-guided modifi-
cation with 2′F-RNA, 2′-O-methyl and PS linkages in both
the crRNA and tracrRNA and found that heavy modifica-
tion could still support satisfactory gene editing (27). While
informative, these studies did not fully establish clear mech-
anistic or rational rules for guide RNAmodification or cor-
related gene editing results with a biochemical understand-
ing of Cas9 RNP structure–function.
In this study, we sought to establish more fundamen-
tal rules for chemical modification that correlate with the
intrinsic biochemical activity of Cas9. These guidelines
are likely to impact a wide range of CRISPR applica-
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tions. In a previous study of crRNA structure-function, we
took advantage of the excellent probing properties of 2′-
deoxynucleotides. Substituting RNA with DNA at specific
residues provided characterization of 2′-hydroxyl contacts,
steric flexibility and A-form helical structure. Systematic
substitution suggested strong preferences for A-form heli-
cal structure in the crRNA, a lack of requirement for 2′-
hydroxyl contacts with Cas9, and potential regulatory fea-
tures of the crRNA that could enhance Cas9 activity (32).
Here we more rigorously tested our hypothesis of A-form
helical structure requirements for the crRNA while evalu-
ating the impact of conformational flexibility and steric re-
strictions on Cas9 activity.
We used both commercially available and custom modi-
fied nucleotides that can mimic RNA or DNA nucleotides
and better control crRNA conformation, flexibility, po-
lar contacts and steric constraints. Among the chemically
modified nucleotides we tested, those possessing confor-
mational properties similar to RNA were 2′F-RNA, 2′,5′-
RNA (31–33), LNA (44), 2′,4′-di-C-OMe RNA (51), 2′F-
4′-C-OMe RNA (39,40) and 2′-O-methyl (57). Among
these, 2′F-RNA is one of the most prominent RNA sub-
stitutions in nucleic acid-based applications because of its
C3′-endo sugar pucker that increases binding affinity to tar-
get RNA, increased endonuclease resistance, and small sub-
stituent size (38,61,62). In contrast, 2′F-ANA mimics the
DNA conformation, has minimal steric constraints, pos-
sesses hydrogen bond acceptor potential and has substan-
tial nuclease resistance (63). We found that replacing RNA
bases with 2′F-RNA generally maintained an excellent de-
gree of activity. DNA could sometimes be partially replaced
with 2′F-ANA, such as in the tracr-pairing repeat region. In
contrast, placing 2′F-ANA in positions that require A-form
helical architecture, specifically the seed region, severely re-
duced activity presumably due to its inflexibility. The 2′,5′-
RNA nucleotides were largely detrimental when replacing
RNA. However, when 2′,5′-RNA was used to replace RNA
or 2′F-RNA nucleotides in a mixed nucleotide configura-
tion (crTR5 and crTR6), substantial cleavage was often
observed. Approximately 40% activity was retained when
three of six RNAbases in the seed (in an otherwise all-DNA
crRNA) were replaced with LNA bases (crTR54). Replac-
ing too many RNA bases with ribonucleotides possessing
2′F,4′-OMe and 2′,4′-di-OMe moieties resulted in complete
loss of activity. Instead, these modifications performed bet-
ter when placed at only one or two select positions, as in
the case of siRNAs (48). The effectiveness of DNA and
2′F-RNA suggests that guide flexibility and conformational
preference is a key factor in Cas9′s ability to achieve catalyt-
ically competent conformational states.
Together, our results support a need for A-form structure
throughout the crRNA. A requirement in the guide region,
specifically the seed sequence, likely arises from its role in
nucleation of target hybridization and the sensing of spe-
cific duplex shape by Cas9 in this region (64–66). The tracr-
pairing repeat region is likely to tolerate broader modifi-
cation because hybridization with tracrRNA should help
induce an A-form duplex architecture. The tracr-pairing
region also plays a poorly understood role in modulating
Cas9 activity (32). A-form conformation and flexibility at
or near the junction between the guide and tracr-pairing
region may offer insight into this regulation. For exam-
ple, DNA or 2′F-RNA are tolerated at or near this junc-
tion, but not 2′F-ANA or 2′,5′-RNA. Our results indicate
that modified nucleotides in the crRNA guide region, espe-
cially the seed sequence, that mimic the properties of RNA
will be the most successful. Overuse of modifications with
bulky moieties should be avoided in the seed region. The
use of multiple modification types is supported, which can
take advantage of synergistic effects among modifications.
DNA nucleotides, for example, can offset conformationally
rigid modifications like 2′F-ANA, although both offer po-
tentially advantageous properties when judiciously placed
in the tracr-pairing region.
Previous reports have suggested a difficulty in replacing
predicted Cas9–2′-hydroxyl contacts with chemically mod-
ified nucleotides when trying to preserve gene editing ac-
tivity in cells (27,28,31). Our investigations support this
phenomenon. Although two crRNAs lacking any RNA
residues (crEG2 and crEG6) performed very well in vitro,
they supported very little gene editing inside of cells. Specif-
ically focusing chemical modification on two 2′-hydroxyl
contact positions in the crRNA (crEG7-crEG12) revealed
a clear reduction in editing efficiency for all modification
types tested. Thus, our results further emphasize a discon-
nect between the intrinsic biochemical activity of Cas9 and
its ability to induce gene editing in cells that centers on a
handful of 2′-hydroxyl contacts with the guide RNA.While
several mechanistic causes are possible, the difference in
substrate complexity between in vitro (plasmid DNA) and
cell-based editing (chromatinized DNA) experiments is ev-
ident. Characterizing the source of discrepancy between in
vitro and cell-based activity should provide a path forward
for the generation of CRISPR-Cas9 enzymes that can uti-
lize completely modified guides with high efficiency for gene
editing applications in the future.
CONCLUSION
This study establishes A-form helical structure and steric
constraint as the primary determinants of the crRNA
structure–function relationship with Cas9. Based on this
observation, we identify rational guidelines for chemical
modification of the crRNA sugar–phosphate backbone that
are compatible with Cas9 enzyme activity. In summary, the
guide region prefers an A-form-like architecture, primarily
due to nucleation of target DNA pairing at the seed. The
tracr-pairing region is compatible with a broader array of
modifications due to hybridization with tracrRNAand pos-
sible roles in conformational regulation of Cas9 activity. Po-
tentially bulky modifications should be avoided in the seed
sequence while a broad variety of modifications are likely to
be well-tolerated at crRNA 5′ and 3′ termini (26). The com-
bination of multiple modification types can provide flexibil-
ity in tuning Cas9 activity by combining synergistic prop-
erties. The phenomenon of apparent 2′-hydroxyl require-
ment at certain guide positions, which are dispensable in
vitro, pose restrictions to highly efficient gene editing by
fullymodified guides (27–29,31,32). The discovery of a clear
mechanistic underpinning or the identification of modifi-
cations that can compensate for the positional 2′-hydroxyl
requirement should unlock this restriction and make the
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guidelines established here highly relevant for rational guide
modification.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
FUNDING
National Science and Engineering Council of CANADA
(NSERCC) (to M.J.D); NSERCC Create (to D.O.); South-
ern Illinois University (SIU) Startup Funding (to K.T.G.);
SIU Chemistry Department Gower Fellowship (to Z.J.K.);
SIU Graduate Fellowship (to C.L.B.); United States De-
partment of Defense Amyotrophic Lateral Sclerosis Re-
search Program (ALSRP) Grant (to K.T.G.). Funding for
open access charge: Startup Funding (to K.T.G.).
Conflict of interest statement.None declared.
REFERENCES
1. Bolotin,A., Quinquis,B., Sorokin,A. and Ehrlich,S.D. (2005)
Clustered regularly interspaced short palindrome repeats (CRISPRs)
have spacers of extrachromosomal origin.Microbiology, 151,
2551–2561.
2. Brouns,S.J., Jore,M.M., Lundgren,M., Westra,E.R., Slijkhuis,R.J.,
Snijders,A.P., Dickman,M.J., Makarova,K.S., Koonin,E.V. and van
der Oost,J. (2008) Small CRISPR RNAs guide antiviral defense in
prokaryotes. Science, 321, 960–964.
3. Marraffini,L.A. and Sontheimer,E.J. (2008) CRISPR interference
limits horizontal gene transfer in staphylococci by targeting DNA.
Science, 322, 1843–1845.
4. Mojica,F.J., Diez-Villasenor,C., Garcia-Martinez,J. and Soria,E.
(2005) Intervening sequences of regularly spaced prokaryotic repeats
derive from foreign genetic elements. J. Mol. Evol., 60, 174–182.
5. Barrangou,R., Fremaux,C., Deveau,H., Richards,M., Boyaval,P.,
Moineau,S., Romero,D.A. and Horvath,P. (2007) CRISPR provides
acquired resistance against viruses in prokaryotes. Science, 315,
1709–1712.
6. Garneau,J.E., Dupuis,M.E., Villion,M., Romero,D.A.,
Barrangou,R., Boyaval,P., Fremaux,C., Horvath,P., Magadan,A.H.
and Moineau,S. (2010) The CRISPR/Cas bacterial immune system
cleaves bacteriophage and plasmid DNA. Nature, 468, 67–71.
7. Jiang,F. and Doudna,J.A. (2017) CRISPR-Cas9 structures and
mechanisms. Annu. Rev. Biophys., 46, 505–529.
8. Jinek,M., Chylinski,K., Fonfara,I., Hauer,M., Doudna,J.A. and
Charpentier,E. (2012) A programmable dual-RNA-guided DNA
endonuclease in adaptive bacterial immunity. Science, 337, 816–821.
9. Shmakov,S., Smargon,A., Scott,D., Cox,D., Pyzocha,N., Yan,W.,
Abudayyeh,O.O., Gootenberg,J.S., Makarova,K.S., Wolf,Y.I
et al.2017) Diversity and evolution of class 2 CRISPR-Cas systems.
Nat. Rev. Microbiol., 15, 169–182.
10. Jiang,F., Taylor,D.W., Chen,J.S., Kornfeld,J.E., Zhou,K.,
Thompson,A.J., Nogales,E. and Doudna,J.A. (2016) Structures of a
CRISPR-Cas9 R-loop complex primed for DNA cleavage. Science,
351, 867–871.
11. Nishimasu,H., Ran,F.A., Hsu,P.D., Konermann,S., Shehata,S.I.,
Dohmae,N., Ishitani,R., Zhang,F. and Nureki,O. (2014) Crystal
structure of Cas9 in complex with guide RNA and target DNA. Cell,
156, 935–949.
12. Cong,L., Ran,F.A., Cox,D., Lin,S., Barretto,R., Habib,N., Hsu,P.D.,
Wu,X., Jiang,W., Marraffini,L.A. et al. (2013) Multiplex genome
engineering using CRISPR/Cas systems. Science, 339, 819–823.
13. Mali,P., Yang,L., Esvelt,K.M., Aach,J., Guell,M., DiCarlo,J.E.,
Norville,J.E. and Church,G.M. (2013) RNA-guided human genome
engineering via Cas9. Science, 339, 823–826.
14. Fellmann,C., Gowen,B.G., Lin,P.C., Doudna,J.A. and Corn,J.E.
(2017) Cornerstones of CRISPR-Cas in drug discovery and therapy.
Nat. Rev. Drug Discov., 16, 89–100.
15. Wright,A.V., Nunez,J.K. and Doudna,J.A. (2016) Biology and
applications of CRISPR systems: harnessing nature’s toolbox for
genome engineering. Cell, 164, 29–44.
16. Bisaria,N., Jarmoskaite,I. and Herschlag,D. (2017) Lessons from
enzyme kinetics reveal specificity principles for RNA-guided
nucleases in RNA interference and CRISPR-Based genome editing.
Cell Syst., 4, 21–29.
17. Nilsen,T.W. (2015) Nucleotide analog interference mapping. Cold
Spring. Harb. Protoc., 2015, 604–608.
18. Saenger,W. (1984) Principles of Nucleic Acid Structure.
Springer-Verlag New York Inc., NY.
19. Deleavey,G.F. and Damha,M.J. (2012) Designing chemically modified
oligonucleotides for targeted gene silencing. Chem. Biol., 19, 937–954.
20. Manoharan,M. (1999) 2′-carbohydrate modifications in antisense
oligonucleotide therapy: importance of conformation, configuration
and conjugation. Biochim. Biophys. Acta, 1489, 117–130.
21. Stein,C.A. and Castanotto,D. (2017) FDA-approved oligonucleotide
therapies in 2017.Mol. Ther., 25, 1069–1075.
22. Shen,X. and Corey,D.R. (2018) Chemistry, mechanism and clinical
status of antisense oligonucleotides and duplex RNAs. Nucleic Acids
Res., 46, 1584–1600.
23. Dai,W.J., Zhu,L.Y., Yan,Z.Y., Xu,Y., Wang,Q.L. and Lu,X.J. (2016)
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles.Mol.
Ther. Nucleic Acids, 5, e349.
24. Wilson,R.C. and Gilbert,L.A. (2017) The promise and challenge of in
vivo delivery for genome therapeutics. ACS Chem. Biol., 13, 376–382.
25. Ryan,D.E., Taussig,D., Steinfeld,I., Phadnis,S.M., Lunstad,B.D.,
Singh,M., Vuong,X., Okochi,K.D., McCaffrey,R., Olesiak,M. et al.
(2018) Improving CRISPR-Cas specificity with chemical
modifications in single-guide RNAs. Nucleic Acids Res., 46, 792–803.
26. Hendel,A., Bak,R.O., Clark,J.T., Kennedy,A.B., Ryan,D.E., Roy,S.,
Steinfeld,I., Lunstad,B.D., Kaiser,R.J., Wilkens,A.B. et al. (2015)
Chemically modified guide RNAs enhance CRISPR-Cas genome
editing in human primary cells. Nat. Biotechnol., 33, 985–989.
27. Mir,A., Alterman,J.F., Hassler,M.R., Debacker,A.J., Hudgens,E.,
Echeverria,D., Brodsky,M.H., Khvorova,A., Watts,J.K. and
Sontheimer,E.J. (2018) Heavily and fully modified RNAs guide
efficient SpyCas9-mediated genome editing. Nat. Commun., 9, 2641.
28. Rahdar,M., McMahon,M.A., Prakash,T.P., Swayze,E.E.,
Bennett,C.F. and Cleveland,D.W. (2015) Synthetic CRISPR
RNA-Cas9-guided genome editing in human cells. Proc. Natl. Acad.
Sci. U.S.A., 112, E7110–E7117.
29. Yin,H., Song,C.Q., Suresh,S., Kwan,S.Y., Wu,Q., Walsh,S., Ding,J.,
Bogorad,R.L., Zhu,L.J., Wolfe,S.A. et al. (2018) Partial DNA-guided
Cas9 enables genome editing with reduced off-target activity. Nat.
Chem. Biol., 14, 311–316.
30. Yin,H., Song,C.Q., Suresh,S., Wu,Q., Walsh,S., Rhym,L.H.,
Mintzer,E., Bolukbasi,M.F., Zhu,L.J., Kauffman,K. et al. (2017)
Structure-guided chemical modification of guide RNA enables potent
non-viral in vivo genome editing. Nat. Biotechnol., 35, 1179–1187.
31. Rueda,F.O., Bista,M., Newton,M.D., Goeppert,A.U., Cuomo,M.E.,
Gordon,E., Kroner,F., Read,J.A., Wrigley,J.D., Rueda,D. et al. (2017)
Mapping the sugar dependency for rational generation of a
DNA-RNA hybrid-guided Cas9 endonuclease. Nat. Commun., 8,
1610.
32. Kartje,Z.J., Barkau,C.L., Rohilla,K.J., Ageely,E.A. and Gagnon,K.T.
(2018) Chimeric guides probe and enhance Cas9 biochemical activity.
Biochemistry, 57, 3027–3031.
33. Dagdas,Y.S., Chen,J.S., Sternberg,S.H., Doudna,J.A. and Yildiz,A.
(2017) A conformational checkpoint between DNA binding and
cleavage by CRISPR-Cas9. Sci. Adv., 3, eaao0027.
34. Sternberg,S.H., LaFrance,B., Kaplan,M. and Doudna,J.A. (2015)
Conformational control of DNA target cleavage by CRISPR-Cas9.
Nature, 527, 110–113.
35. Anders,C. and Jinek,M. (2014) In vitro enzymology of Cas9.
Methods Enzymol., 546, 1–20.
36. Lim,Y., Bak,S.Y., Sung,K., Jeong,E., Lee,S.H., Kim,J.S., Bae,S. and
Kim,S.K. (2016) Structural roles of guide RNAs in the nuclease
activity of Cas9 endonuclease. Nat. Commun., 7, 13350.
37. Makarova,K.S., Wolf,Y.I., Alkhnbashi,O.S., Costa,F., Shah,S.A.,
Saunders,S.J., Barrangou,R., Brouns,S.J., Charpentier,E., Haft,D.H.
et al. (2015) An updated evolutionary classification of CRISPR-Cas
systems. Nat. Rev. Microbiol., 13, 722–736.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gky1214/5229206 by Southern Illinois U
niversity C
arbondale,  ktgagnon@
siu.edu on 04 D
ecem
ber 2018
Nucleic Acids Research, 2018 13
38. Patra,A., Paolillo,M., Charisse,K., Manoharan,M., Rozners,E. and
Egli,M. (2012) 2′-Fluoro RNA shows increased Watson-Crick
H-bonding strength and stacking relative to RNA: evidence from
NMR and thermodynamic data. Angew. Chem. Int. Ed. Engl., 51,
11863–11866.
39. Kulkarni,M. and Mukherjee,A. (2017) Understanding B-DNA to
A-DNA transition in the right-handed DNA helix: perspective from a
local to global transition. Prog. Biophys. Mol. Biol., 128, 63–73.
40. Giannaris,P.A. and Damha,M.J. (1993) Oligoribonucleotides
containing 2′,5′-phosphodiester linkages exhibit binding selectivity
for 3′,5′-RNA over 3′,5′-ssDNA. Nucleic Acids Res., 21, 4742–4749.
41. Sheng,J., Li,L., Engelhart,A.E., Gan,J., Wang,J. and Szostak,J.W.
(2014) Structural insights into the effects of 2′-5′ linkages on the
RNA duplex. Proc. Natl. Acad. Sci. U.S.A., 111, 3050–3055.
42. Wasner,M., Arion,D., Borkow,G., Noronha,A., Uddin,A.H.,
Parniak,M.A. and Damha,M.J. (1998) Physicochemical and
biochemical properties of 2′,5′-linked RNA and
2′,5′-RNA:3′,5′-RNA “hybrid” duplexes. Biochemistry, 37,
7478–7486.
43. Shen,F., Luo,Z., Liu,H., Wang,R., Zhang,S., Gan,J. and Sheng,J.
(2017) Structural insights into RNA duplexes with multiple
2-5-linkages. Nucleic Acids Res., 45, 3537–3546.
44. Aartsma-Rus,A. (2017) FDA Approval of Nusinersen for Spinal
Muscular Atrophy Makes 2016 the Year of Splice Modulating
Oligonucleotides. Nucleic Acid Ther., 27, 67–69.
45. Mangos,M.M., Min,K.L., Viazovkina,E., Galarneau,A.,
Elzagheid,M.I., Parniak,M.A. and Damha,M.J. (2003) Efficient
RNase H-directed cleavage of RNA promoted by antisense DNA or
2′F-ANA constructs containing acyclic nucleotide inserts. J. Am.
Chem. Soc., 125, 654–661.
46. Martin-Pintado,N., Yahyaee-Anzahaee,M., Campos-Olivas,R.,
Noronha,A.M., Wilds,C.J., Damha,M.J. and Gonzalez,C. (2012) The
solution structure of double helical arabino nucleic acids (ANA and
2′F-ANA): effect of arabinoses in duplex-hairpin interconversion.
Nucleic Acids Res., 40, 9329–9339.
47. Min,K.L., Viazovkina,E., Galarneau,A., Parniak,M.A. and
Damha,M.J. (2002) Oligonucleotides comprised of alternating
2′-deoxy-2′-fluoro-beta-D-arabinonucleosides and
D-2′-deoxyribonucleosides (2′F-ANA/DNA ‘altimers’) induce
efficient RNA cleavage mediated by RNase H. Bioorg. Med. Chem.
Lett., 12, 2651–2654.
48. Malek-Adamian,E., Guenther,D.C., Matsuda,S.,
Martinez-Montero,S., Zlatev,I., Harp,J., Burai Patrascu,M.,
Foster,D.J., Fakhoury,J., Perkins,L. et al. (2017)
4′-C-Methoxy-2′-deoxy-2′-fluoro modified ribonucleotides improve
metabolic stability and elicit efficient RNAi-Mediated gene silencing.
J. Am. Chem. Soc., 139, 14542–14555.
49. Burai Patrascu,M., Malek-Adamian,E., Damha,M.J. and
Moitessier,N. (2017) Accurately modeling the conformational
preferences of nucleosides. J. Am. Chem. Soc., 139, 13620–13623.
50. Harp,J.M., Guenther,D.C., Bisbe,A., Perkins,L., Matsuda,S.,
Bommineni,G.R., Zlatev,I., Foster,D.J., Taneja,N., Charisse,K. et al.
(2018) Structural basis for the synergy of 4′- and 2′-modifications on
siRNA nuclease resistance, thermal stability and RNAi activity.
Nucleic Acids Res., 46, 8090–8104.
51. Malek-Adamian,E., Patrascu,M.B., Jana,S.K., Martinez-Montero,S.,
Moitessier,N. and Damha,M.J. (2018) Adjusting the structure of
2′-Modified nucleosides and oligonucleotides via C4′-alpha-F or
C4′-alpha-OMe Substitution: Synthesis and conformational analysis.
J. Org. Chem., 83, 9839–9849.
52. Salazar,M., Fedoroff,O.Y., Miller,J.M., Ribeiro,N.S. and Reid,B.R.
(1993) The DNA strand in DNA.RNA hybrid duplexes is neither
B-form nor A-form in solution. Biochemistry, 32, 4207–4215.
53. Wahl,M.C. and Sundaralingam,M. (2000) B-form to A-form
conversion by a 3′-terminal ribose: crystal structure of the chimera
d(CCACTAGTG)r(G). Nucleic Acids Res., 28, 4356–4363.
54. Martin-Pintado,N., Deleavey,G.F., Portella,G., Campos-Olivas,R.,
Orozco,M., Damha,M.J. and Gonzalez,C. (2013) Backbone
FC-H. . .O hydrogen bonds in 2′F-substituted nucleic acids. Angew.
Chem. Int. Ed. Engl., 52, 12065–12068.
55. Koshkin,A.A., singh,S.K., Nielsen,P., Rajwanshi,V.K., Kumar,R.,
Meldgaard,M., Olsen,C.E. and Wengel,J. (1998) LNA (Locked
Nucleic Acids): synthesis of the adenine, cytosine, guanine,
5-methylcytosine, thymine and uracil bicyclonucleoside monomers,
oligomerisation, and unprecedented nucleic acid recognition.
Tetrahedron, 54, 3607–3630.
56. Langkjaer,N., Pasternak,A. and Wengel,J. (2009) UNA (unlocked
nucleic acid): a flexible RNA mimic that allows engineering of nucleic
acid duplex stability. Bioorg. Med. Chem., 17, 5420–5425.
57. Lubini,P., Zurcher,W. and Egli,M. (1994) Stabilizing effects of the
RNA 2′-substituent: crystal structure of an oligodeoxynucleotide
duplex containing 2′-O-methylated adenosines. Chem. Biol., 1, 39–45.
58. Uhlmann,E. and Peyman,A. (1990) Antisense oligonucleotides: a new
therapeutic principle. Chem. Rev., 90, 543–584.
59. Gagnon,K.T. and Corey,D.R. (2015) Stepping toward therapeutic
CRISPR. Proc. Natl. Acad. Sci. U.S.A., 112, 15536–15537.
60. Cromwell,C.R., Sung,K., Park,J., Krysler,A.R., Jovel,J., Kim,S.K.
and Hubbard,B.P. (2018) Incorporation of bridged nucleic acids into
CRISPR RNAs improves Cas9 endonuclease specificity. Nat.
Commun., 9, 1448.
61. Kawasaki,A.M., Casper,M.D., Freier,S.M., Lesnik,E.A.,
Zounes,M.C., Cummins,L.L., Gonzalez,C. and Cook,P.D. (1993)
Uniformly modified 2′-deoxy-2′-fluoro phosphorothioate
oligonucleotides as nuclease-resistant antisense compounds with high
affinity and specificity for RNA targets. J. Med. Chem., 36, 831–841.
62. Pallan,P.S., Greene,E.M., Jicman,P.A., Pandey,R.K.,
Manoharan,M., Rozners,E. and Egli,M. (2011) Unexpected origins
of the enhanced pairing affinity of 2′-fluoro-modified RNA. Nucleic
Acids Res., 39, 3482–3495.
63. Watts,J.K., Martin-Pintado,N., Gomez-Pinto,I., Schwartzentruber,J.,
Portella,G., Orozco,M., Gonzalez,C. and Damha,M.J. (2010)
Differential stability of 2′F-ANA*RNA and ANA*RNA hybrid
duplexes: roles of structure, pseudohydrogen bonding, hydration, ion
uptake and flexibility. Nucleic Acids Res., 38, 2498–2511.
64. Jiang,F., Zhou,K., Ma,L., Gressel,S. and Doudna,J.A. (2015) A
Cas9-guide RNA complex preorganized for target DNA recognition.
Science, 348, 1477–1481.
65. Sternberg,S.H., Redding,S., Jinek,M., Greene,E.C. and Doudna,J.A.
(2014) DNA interrogation by the CRISPR RNA-guided
endonuclease Cas9. Nature, 507, 62–67.
66. Semenova,E., Jore,M.M., Datsenko,K.A., Semenova,A.,
Westra,E.R., Wanner,B., van der Oost,J., Brouns,S.J. and
Severinov,K. (2011) Interference by clustered regularly interspaced
short palindromic repeat (CRISPR) RNA is governed by a seed
sequence. Proc. Natl. Acad. Sci. U.S.A., 108, 10098–10103.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gky1214/5229206 by Southern Illinois U
niversity C
arbondale,  ktgagnon@
siu.edu on 04 D
ecem
ber 2018
